Pfizer Italia S.p.A. (manufacturing GLZ; quality control at batch release for parameter "Sterility") / PPD Development, L.P. (quality control in stability study for parameter "Neutralization analysis of TNF-alpha using NF-kB reporter gene")

The drug is prescribed for the treatment of rheumatoid arthritis, Crohn's disease (in adults and children), ulcerative colitis (in adults and children), ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Dosage form: powder for concentrate for infusion solution

ATC: L04AB02